Humans have long been plagued by a myriad of deadly cancers. Parallelly, they attempted different permutations and combinations of treatments to cure the disease. Attempts involving biomolecular targets have come to the fore in recent years. Like a broad-spectrum antibiotic that can attack and eliminate several microbes at a time, some of these biomolecular targets, when manipulated appropriately, can alleviate different cancers. One such biomolecular target of interest is LIM domain only 1 gene (LMO1).